Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Radio America. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Radio America or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Trump vs. Big Pharma: Art of the Deal or Just Another Executive Order?

6:13
 
Share
 

Manage episode 482316778 series 1081845
Content provided by Radio America. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Radio America or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Listen on:
Apple Podcasts:https://podcasts.apple.com/us/podcast/watchdog-on-wall-street-with-chris-markowski/id570687608
Spotify: https://open.spotify.com/show/2PtgPvJvqc2gkpGIkNMR5i
Watch on: https://www.youtube.com/@WatchdogOnWallstreet/featured
Chris breaks down Trump’s executive order aimed at lowering U.S. prescription drug prices—and why it likely won’t survive a legal challenge. He explains how Americans bear the brunt of global R&D costs due to foreign price controls and argues that real reform lies in negotiation, not government-mandated price fixing. Markowski draws from his experience in pharmaceutical investment banking to expose the high stakes of drug development and offers potential “Art of the Deal” tactics Trump could use—like restricting pharma ad spending—to push foreign governments to pay their fair share. He warns that true price controls would kill innovation and devastate the industry. www.watchdogonwallstreet.com
  continue reading

1700 episodes

Artwork
iconShare
 
Manage episode 482316778 series 1081845
Content provided by Radio America. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Radio America or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Listen on:
Apple Podcasts:https://podcasts.apple.com/us/podcast/watchdog-on-wall-street-with-chris-markowski/id570687608
Spotify: https://open.spotify.com/show/2PtgPvJvqc2gkpGIkNMR5i
Watch on: https://www.youtube.com/@WatchdogOnWallstreet/featured
Chris breaks down Trump’s executive order aimed at lowering U.S. prescription drug prices—and why it likely won’t survive a legal challenge. He explains how Americans bear the brunt of global R&D costs due to foreign price controls and argues that real reform lies in negotiation, not government-mandated price fixing. Markowski draws from his experience in pharmaceutical investment banking to expose the high stakes of drug development and offers potential “Art of the Deal” tactics Trump could use—like restricting pharma ad spending—to push foreign governments to pay their fair share. He warns that true price controls would kill innovation and devastate the industry. www.watchdogonwallstreet.com
  continue reading

1700 episodes

Усі епізоди

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play